Transpara Announces New FDA Clearance Designed to Improve Breast Cancer Detection at RSNA
ScreenPoint Medical to Showcase Innovative FDA Cleared Capabilities including Breast Density Assessment and Temporal Comparison to Elevate Radiologist Performance